Scientists have identified new therapeutic targets for the treatment of multiple sclerosis.They provide fresh answers concerning the role of novel adhesion molecules in the pathogenesis of MS, a chronic autoimmune disease of the nervous system.
Scientists have identified new therapeutic targets for the treatment of multiple sclerosis.They provide fresh answers concerning the role of novel adhesion molecules in the pathogenesis of MS, a chronic autoimmune disease of the nervous system.